- Home
- WALD vs ABEO Comparison
WALD vs ABEO Comparison
Compare WALD & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WALD
- ABEO
- Stock Information
- Founded
- WALD 1988
- ABEO 1974
- Country
- WALD United States
- ABEO United States
- Employees
- WALD N/A
- ABEO N/A
- Industry
- WALD Package Goods/Cosmetics
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- WALD Consumer Discretionary
- ABEO Health Care
- Exchange
- WALD Nasdaq
- ABEO Nasdaq
- Market Cap
- WALD 306.3M
- ABEO 332.0M
- IPO Year
- WALD 2021
- ABEO 1980
- Fundamental
- Price
- WALD $1.73
- ABEO $7.23
- Analyst Decision
- WALD Strong Buy
- ABEO Strong Buy
- Analyst Count
- WALD 5
- ABEO 6
- Target Price
- WALD $4.96
- ABEO $18.17
- AVG Volume (30 Days)
- WALD 477.4K
- ABEO 720.5K
- Earning Date
- WALD 09-02-2025
- ABEO 08-14-2025
- Dividend Yield
- WALD N/A
- ABEO N/A
- EPS Growth
- WALD N/A
- ABEO N/A
- EPS
- WALD N/A
- ABEO 0.99
- Revenue
- WALD $273,868,000.00
- ABEO $400,000.00
- Revenue This Year
- WALD $14.78
- ABEO N/A
- Revenue Next Year
- WALD $15.84
- ABEO $322.37
- P/E Ratio
- WALD N/A
- ABEO $7.30
- Revenue Growth
- WALD 25.55
- ABEO N/A
- 52 Week Low
- WALD $1.50
- ABEO $3.93
- 52 Week High
- WALD $4.74
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- WALD 40.76
- ABEO 65.32
- Support Level
- WALD $1.50
- ABEO $6.70
- Resistance Level
- WALD $1.98
- ABEO $7.54
- Average True Range (ATR)
- WALD 0.16
- ABEO 0.29
- MACD
- WALD 0.01
- ABEO 0.05
- Stochastic Oscillator
- WALD 38.33
- ABEO 78.32
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.